Literature DB >> 2692937

Antiparasitic drugs in children.

N J White1.   

Abstract

Many of the children living in tropical areas of the world are infected by a variety of human parasites. As a group, the antiparasitic drugs can claim to be the least studied of all compounds in current clinical use. There is little information on the disposition of these drugs in children, and most treatment recommendations are either empirical or by extrapolation from observations in adults. Many of the older drugs used in systemic parasitic infections have narrow therapeutic ratios and could be better used if treatment regimens were based on detailed pharmacokinetic and pharmacodynamic information. This review summarises existing information on these drugs and suggests provisional recommendations for antiparasitic treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692937     DOI: 10.2165/00003088-198900171-00010

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  85 in total

1.  Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole.

Authors:  R Norrby; T Eilard; A Svedhem; E Lycke
Journal:  Scand J Infect Dis       Date:  1975

2.  Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.

Authors:  J D Chulay; L Fleckenstein; D H Smith
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

3.  Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies.

Authors:  D E Schwartz; W Vetter; G Englert
Journal:  Arzneimittelforschung       Date:  1970-12

4.  Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.

Authors:  F Nosten; S Imvithaya; M Vincenti; G Delmas; G Lebihan; B Hausler; N White
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

5.  Treatment of quinine resistant falciparum malaria in Thai children.

Authors:  T Chongsuphajaisiddhi; A Sabchareon; P Attanath
Journal:  Southeast Asian J Trop Med Public Health       Date:  1983-09       Impact factor: 0.267

6.  The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.

Authors:  M Frisk-Holmberg; Y Bergqvist; E Termond; B Domeij-Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 7.  Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.

Authors:  G D Overturf
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

8.  Effect of azotemia in dogs on the pharmacokinetics of pentamidine.

Authors:  T R Navin; C M Dickinson; S R Adams; M Mayersohn; D D Juranek
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

9.  The effect of variations in urinary pH on the pharmacokinetics of diethylcarbamazine.

Authors:  G Edwards; A M Breckenridge; K K Adjepon-Yamoah; M L Orme; S A Ward
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

10.  A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya.

Authors:  J D Chulay; S M Bhatt; R Muigai; M Ho; G Gachihi; J B Were; C Chunge; A D Bryceson
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.